Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamide

Cancer

Volumn 30, Issue 3, 1972, Pages 621-627

  Bergsagel, D E ^a   Jenkin, R D T ^a,b   Pringle, J F ^a,c   White, D M ^d   Fetterly, J C M ^d   Klaassen, D J ^e,g   McDermot, R S R ^f  

^a UNIVERSITY OF TORONTO   (Canada)

^b Prince Margaret Hospital   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e OTTAWA REGIONAL CANCER CENTRE   (Canada)

^f Ontario Cancer Foundation   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; CYCLOPHOSPHAMIDE;

ARTICLE; CARCINOMA; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; MEDIASTINUM; METASTASIS; MORTALITY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TIME;

CARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COBALT ISOTOPES; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MEDIASTINUM; NEOPLASM METASTASIS; TIME FACTORS;

EID: 0015402248     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197209)30:3<621::AID-CNCR2820300305>3.0.CO;2-0     Document Type: Article

References (8)

1. Effect of cyclophosphamide on advanced lung cancer and hematological toxicity of large, intermittent intravenous doses
2. A randomized study of irradiation and vinblastine in lung cancer
3. Comparison of treatment policies in inoperable bronchial carcinoma
4. Alkylating agents in bronchogenic carcinoma
5. A clinical pharmacologic study of chemotherapy and X‐ray therapy in lung cancer
6. New approaches in administration of anticancer drugs
7. Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy